Amethyst Radiotherapy Austria and IASO Health GmbH Partner to Expand Cross-Border Access to Advanced Cancer Care

Amethyst Austria and IASO‑Health Partner to Expand Cancer Care Across Borders

/in

Vienna, Austria / Bad Ragaz, Switzerland – July 16, 2025

Amethyst Radiotherapy Austria , part of the Amethyst Healthcare Group, has entered into a new partnership with IASO‑Health GmbH , a Swiss-based integrative medicine provider led by CEO and Founder Bruno Rosset. This collaboration strengthens cross-border oncology pathways, giving IASO‑Health patients direct access to cutting-edge radiotherapy at Amethyst’s center in the prestigious Wiener Privatklinik in Vienna.

Precision Radiotherapy Meets Integrative Oncology

At the heart of the Vienna center is the Elekta Versa HD linear accelerator, a world-class system offering highly accurate and personalised treatment. The center delivers:

  • External Beam Radiation Therapy (EBRT)
  • Intensity-Modulated Radiotherapy (IMRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Stereotactic Radiosurgery (SRS) and Radiotherapy (SRT) for millimeter-level precision

Complemented by Cone-Beam CT, HexaPOD 6D couch, multileaf collimators, and in-vivo dose monitoring, the center ensures maximum targeting accuracy with minimal impact on surrounding healthy tissue.

Through this collaboration, IASO‑Health patients — many already receiving dendritic cell-based immunotherapy — will benefit from prioritised access, seamless scheduling, and coordinated treatment planning across Austria, Germany, and Switzerland.

 

Bruno Rosset, CEO & Founder of IASO‑Health:
“This partnership allows us to combine innovative immunotherapy with Amethyst Austria’s advanced radiotherapy, creating a truly integrated patient experience.”

Paul Stuchetz, Managing Director, Amethyst Radiotherapy Austria:
“Since opening in 2020, our center has remained committed to precision oncology. This partnership strengthens that mission by offering faster, high-quality access for IASO‑Health patients.”

Dr. David Kuczer, Clinical Lead and Partner Radiation Oncologist:
“Our expertise in stereotactic and modulated therapies is enhanced by this collaboration. We’re proud to support IASO‑Health patients with world-class technology and holistic care coordination.”

 

Aligned with Amethyst Healthcare Group’s European Vision

This partnership reflects Amethyst Healthcare Group’s broader strategy to foster international collaborations that improve cancer treatment accessibility and quality. By supporting regionally led partnerships like this, the Group continues to deliver patient-centred oncology care across borders.

 

Media contact: [email protected]